Related Experiment Videos
Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment
N Stefanova1, K Seppi, C Scherfler
1Department of Neurology, University Hospital, Innsbruck, Austria.
Journal of Neural Transmission. Supplementum
|February 24, 2001
Summary
Depression is a common feature in alpha-synucleinopathies like Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). This review covers depression's epidemiology, pathophysiology, and treatment in these related neurodegenerative disorders.
Area of Science:
- Neuroscience
- Neurology
- Pathology
Background:
- Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are alpha-synucleinopathies.
- These disorders share a common pathology of alpha-synuclein aggregation.
Purpose of the Study:
- To review depression in alpha-synucleinopathies.
- To discuss epidemiological, pathophysiological, and treatment aspects of depression in PD, DLB, and MSA.
Main Methods:
- Literature review.
- Synthesis of existing research on depression in alpha-synucleinopathies.
Main Results:
- Depression is a frequent and disabling symptom in PD, DLB, and MSA.
- Shared underlying pathology may contribute to similar depressive symptoms across these conditions.
Conclusions:
- Depression requires attention in the management of alpha-synucleinopathies.
- Further research into the specific mechanisms and treatments for depression in these disorders is warranted.